Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:ISIS
Date5/1991
Raised
Post IPO Valuation

General Information

Websiteisispharm.com
CategoryBioTech
Phone760-931-9200
Employees

Offices

Carlsbad, USA
2855 Gazelle Court
Carlsbad, CA, 92010
USA

People

Chairman of the Board and Chief Executive Officer
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People

Funding

DEBT TOTAL $201M
Debt, 8/2012
$201M

Tags

Isis Pharmaceuticals

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis’ broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer. Isis’ partner, Genzyme, plans to commercialize Isis’ lead product, KYNAMRO™, in the United States and Europe following regulatory approval. Isis’ patents provide strong and extensive protection for its drugs and technology.

Recent Milestones

Videos

Screenshots

Isis Pharmaceuticals screenshot
Above: Isis Pharmaceuticals
Uploaded: 12/12/12

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. Isis earns $7.5M milestone on PhII/III trial launch (fiercebiotech.com) [edit]
    Isis Pharmaceuticals, Inc. (ISIS) Receives $10 Million Milestone Payment (biospace.com) [edit]
    Isis Pharmaceuticals receives $6m payment from AstraZeneca PBR Staff Writer (contractresearch.pharmaceutical-business-review.com) [edit]
    Isis Earns $7 Million in Milestone Payments from GSK for Advancement of ISIS-GSK3 Rx to Treat Viral Infection (ir.isispharm.com) [edit]
    Isis gets $3m from GSK for PhI trial of antiviral (pharmatimes.com) [edit]
Edit This Page
Last Edited 3/5/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy